Free delivery nationwide for orders above ₱800

 
RXDRUG-DRP-6781-1pc

METACARD MR Trimetazidine Hydrochloride 35mg Modified-Release Tablet 1's

Contact us for a price
Out of stock
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Description

Indications/Uses

Metacard MR Tablet is a metabolic treatment for ischemic heart disease. It can be used at all stages of angina pectoris and in post myocardial infarction. Metacard MR therapy has also demonstrated beneficial effects when administered during bypass surgery.

Dosage/Direction for Use

One tablet at mealtimes in the morning and evening.

Contraindications

Trimetazidine is contraindicated in - patients with a known hypersensitivity to its components.

Side Effects

Trimetazidine is safe and well tolerated. Rare cases of gastrointestinal disorders, nausea & vomiting have been reported.

Storage

Store below 30°C and protect from light.

MedsGo Class

Anti-Anginal Drugs

Features

Brand
Metacard Mr
Full Details
Dosage Strength
35 mg
Drug Ingredients
  • Trimetazidine
Drug Packaging
Modified-Release Tablet 1's
Generic Name
Trimetazidine Hydrochloride
Dosage Form
Modified-Release Tablet
Registration Number
DRP-6781
Drug Classification
Prescription Drug (RX)
Find similar